New development aims to offer clients improved execution services on an agency basis across listed derivatives and related financial instruments.

or that any of the anticipated milestones by Inventiva or its partners will be reached on their expected timeline, or at all. Future results may turn out to be materially different from the ...

Inventiva’s lead product candidate, lanifibranor, is currently in a pivotal Phase III clinical trial, NATiV3, for the treatment of adult patients with MASH, a common and progressive chronic liver ...

Under the liquidity contract granted to Kepler Cheuvreux by Inventiva ... or that any of the anticipated milestones by Inventiva or its partners will be reached on their expected timeline ...

or that any of the anticipated milestones by Inventiva or its partners will be reached on their expected timeline, or at all. Future results may turn out to be materially different from the ...

Bernstein SocGen Group updated its financial outlook on Coca-Cola (NYSE:KO) HBC AG (CCH:LN) (OTC: CCHGY), increasing the ...

Tuesday saw Kepler Cheuvreux analyst William Mackie upgrade Siemens Energy AG (ETR:ENR1n) (ENR:GR) (OTC: SMEGF) stock rating from Hold to Buy, setting a new price target at €60.50, up from the ...

Wednesday, Kepler Cheuvreux analysts upgraded Severn Trent Plc (LON:SVT:LN) (OTC: SVTRF) stock from Hold to Buy and increased the price target to GBP30.00 from GBP27.00. The analysts cited the ...

We recently compiled a list of the 10 AI News Updates Trending on Wall Street. In this article, we are going to take a look at where Logitech International S.A. (NASDAQ:LOGI) stands against the ...